p53 immunostaining of surgical margins as a predictor of local recurrence in squamous cell carcinoma of the oral cavity and oropharynx

Ear, Nose and Throat Journal

Volumn 76, Issue 11, 1997, Pages 818-823

  Ball, Valerie A ^a   Righi, Paul D ^b,d   Tejada, Eduardo ^b   Radpour, Shokri ^b   Pavelic, Zlatko P ^c   Gluckman, Jack L ^c  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b Richard L Roudeboush Vet Aff M   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; OROPHARYNX CARCINOMA; RECURRENCE RISK; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0030716853     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556139707601109     Document Type: Article

References (25)

1. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54:4855-78.
2. Levine AJ, Perry ME, Chang A, et al. The 1993 Walter Hubert lecture: The role of the p53 tumor suppressor gene in tumorigenesis. Br J Cancer 1994; 69:409-16.
3. Oliner JD. Discerning the function of p53 by examining its molecular interactions. Bioessays 1993, 15:703-7.
4. Selter H, Montenarh M. The emerging picture of p53. Int J Biochem 1994; 26:145-54.
5. Tischler RB, Calderwood SK, Coleman CN, et al. Increase in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res 1993; 53:2212-16.
6. Bradford CR, Zhu S, Wolf GT, et al. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Otolaryngol Head Neck Surg 1995; 113:408-12.
7. Nees M, Homann N, Discher H, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: A possible molecular basis for the development of multiple tumors. Cancer Res 1993; 53:4189-96.
8. Dolcetti R, Doglioni C, Maestro R, et al. p53 over-expression is an early event in the development of human squamous cell carcinoma of the larynx: Genetic and prognostic implications. Int J Cancer 1992; 52:178-82.
9. Somers KD, Merrick MA, Lopez ME, et al. Frequent p53 mutations in head and neck cancer. Cancer Res 1992; 52:5997-6000.
10. Shin DM, Kim J, Ro JY, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994; 54:321-6.
11. Maestro R, Dolcetti R, Gasparotto D, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 1992; 7:1159-66.
12. Koch WM, Boyle JO, Mao L, et al. p53 gene mutations as markers of tumor spread in synchronous oral cancers. Arch Otolaryngol Head Neck Surg 1994; 120:943-7.
13. Bourhis J, Bosq J, Wilson GD, et al. Correlation between p53 gene expression and tumor cell proliferation in oropharyngeal cancer. Int J Cancer 1994; 57:458-62.
14. Zambetti GP, Levine AA. A comparison of the biological activities of wild-type and mutant p53. Faseb J 1993; 7:855-65.
15. Field JK, Spandidos DA, Mallin A, et al. Elevated p53 expression with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991; 64:573-7.
16. Somers KD, Schechter GL. Genetic alterations in head and neck cancer. Otolaryngol Clin North Am 1992; 5:1065-71.
17. Field JK, Zoumpourlis V, Spandidos DA, et al. p53 expression and mutations in squamous cell carcinoma of the head and neck: Expression correlates with the patients' use of tobacco and alcohol. Cancer Detect Prevent 1994; 18:197-208.
18. Brennan JA, Mao L, Hruban RH, et al. Molecular assessment of histopathological staging in squamous cell carcinoma of the head and neck. N Eng J Med 1995; 332:429-35.
19. Pavelic ZP, Portugal LG, Gootee MJ, et al. Retrieval of p53 in paraffin-embeded head and neck tumor tissues. Arch Otolaryngol Head Neck Surg 1993; 119:1206-9.
20. Pavelic AP, Gluckman JL, Gapany M, et al. Improved immunohistochemical detection of p53 protein in paraffin-embeded tisues reveals elevated levels in most head and neck and lung carcinomas: Correlation with clinicopathologic parameters. Antican Res 1992; 12:1389-94.
21. Jesse R, Sugarbaker E. Squamous cell carcinoma of the oropharynx: Why we fail. Am J Surg 1976; 132:435-8.
22. Candour-Edwards RF, Donald PJ, Lie JT. Clinical utility of intraoperative frozen section diagnosis in head and neck surgery: A quality assurance perspective. Head Neck 1993; 15:373-6.
23. Lee G. Detection of residual carcinoma of the oral cavity, oropharynx, hypopharynx and larynx: A study of surgical margins. Trans Am Acad Ophthalmol Otolaryngol 1974; 78:49-53.
24. Chen TY, Emrich LJ, Driscol DL. The clinical significance of pathological findings in surgically resected margins of the primary tumor in head and neck carcinoma. Int J Oncol Biol Phys 1987; 13:833-7.
25. Chang EH, Jang YJ, Hao Z. Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy. Arch Otolaryngol Head Neck Surg 1997; 123:507-12.